PDO Screen – Patient-derived Organoids meet Cancer Modeling
Discover how patient-derived organoids can revolutionize oncology research by enabling accurate modeling of tumor biology and predicting patient response to treatment.
HUB's blog
The FDA Modernization Act 2.0: A patient-centric paradigm shift in drug development
Explore what the new legislative bill means for the future of ...